Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats

doi:10.3748/wjg.v21.i7.2058

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8255)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

558

WORD

332

HTML

5022

Figures (1-6)

162

Tables (1-2)

133

Sum=6207

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

976

Download

1072

Sum=2048

Feb 21, 2015 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (45)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 21, 2015; 21(7): 2058-2066
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2058

Full Size Figure Download Figure

Figure 1 General structure of dammarane-type gypenosides consisting of both the hydrophobic sapogenin part and the hydrophilic sugar part in the molecule (where R1 and R2 = glucose, rhamnose; R3 = glucose, xylose).

Citation: He Q, Li JK, Li F, Li RG, Zhan GQ, Li G, Du WX, Tan HB. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World J Gastroenterol 2015; 21(7): 2058-2066
URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2058.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2058